• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用 Eudragit® L100 和 Eudragit® S100 从胰腺匀浆中浓缩和纯化胰凝乳蛋白酶的简单方法。

A simple method of chymotrypsin concentration and purification from pancreas homogenate using Eudragit® L100 and Eudragit® S100.

机构信息

Physical-Chemistry Department, Faculty of Biochemical and Pharmaceutical Sciences, National University of Rosario, FonCyT and CONICET, Suipacha 570, (S2002RLK) Rosario, Argentina.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Apr 15;879(13-14):1003-7. doi: 10.1016/j.jchromb.2011.02.037. Epub 2011 Mar 1.

DOI:10.1016/j.jchromb.2011.02.037
PMID:21419720
Abstract

The condition of chymotrypsin (ChTRP)-Eudragit® (Eu) insoluble complex formation was studied with the aim of applying this information to the separation of chymotrypsin from a crude filtrate of bovine pancreas homogenate. The optimal pH of the complex precipitation was 4.60 for ChTRP-Eudragit® L100 and 5.40 for ChTRP-Eudragit® S100. The polyelectrolyte concentration necessary for the commercial enzyme precipitation was lower than 0.1% (w/v). The complex formation was inhibited by NaCl for both polyelectrolytes. The method was applied to recover the enzyme from bovine homogenate; ChTRP was precipitated by Eudragit® addition. The non-soluble complexes were separated by simple centrifugation and re-dissolved by a pH change to 8.20. The best conditions to recover ChTRP brought about a purification factor of around 4 and 90% yield.

摘要

研究了糜蛋白酶(ChTRP)-Eudragit®(Eu)不溶性复合物形成的条件,旨在将此信息应用于从牛胰脏匀浆的粗滤物中分离糜蛋白酶。ChTRP-Eudragit® L100 的最佳复合物沉淀 pH 值为 4.60,ChTRP-Eudragit® S100 的最佳复合物沉淀 pH 值为 5.40。对于商业酶沉淀,所需的聚电解质浓度低于 0.1%(w/v)。两种聚电解质都抑制了 NaCl 对复合物形成的抑制作用。该方法应用于从牛匀浆中回收酶;通过添加 Eudragit®沉淀糜蛋白酶。通过简单的离心分离不溶性复合物,然后通过将 pH 值改变至 8.20 重新溶解。回收 ChTRP 的最佳条件可获得约 4 倍的纯化因子和 90%的产率。

相似文献

1
A simple method of chymotrypsin concentration and purification from pancreas homogenate using Eudragit® L100 and Eudragit® S100.采用 Eudragit® L100 和 Eudragit® S100 从胰腺匀浆中浓缩和纯化胰凝乳蛋白酶的简单方法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Apr 15;879(13-14):1003-7. doi: 10.1016/j.jchromb.2011.02.037. Epub 2011 Mar 1.
2
Analysis of the interactions between Eudragit® L100 and porcine pancreatic trypsin by calorimetric techniques.通过量热技术分析 Eudragit® L100 与猪胰蛋白酶之间的相互作用。
Int J Biol Macromol. 2012 Jan 1;50(1):180-6. doi: 10.1016/j.ijbiomac.2011.10.016. Epub 2011 Oct 25.
3
Extraction of trypsin from bovine pancreas by applying polyethyleneglycol/sodium citrate aqueous two-phase systems.应用聚乙二醇/柠檬酸钠双水相体系从牛胰腺中提取胰蛋白酶。
J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jan 15;877(3):115-20. doi: 10.1016/j.jchromb.2008.11.016. Epub 2008 Nov 14.
4
Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.壳聚糖与尤特奇L100和尤特奇L100-55形成的聚电解质复合物作为口服控释药物潜在载体的比较评价
Eur J Pharm Biopharm. 2008 Sep;70(1):215-25. doi: 10.1016/j.ejpb.2008.04.008. Epub 2008 Apr 22.
5
Physicochemical properties of enteric films prepared from aqueous dispersions and organic solutions.由水分散体和有机溶液制备的肠溶薄膜的物理化学性质。
Int J Pharm. 2006 Apr 26;313(1-2):43-8. doi: 10.1016/j.ijpharm.2006.01.021. Epub 2006 Feb 17.
6
Physicochemical study of the formation of complexes between pancreatic proteases and polyanions.胰腺蛋白酶与聚阴离子之间复合物形成的物理化学研究。
Int J Biol Macromol. 2015 Aug;79:160-6. doi: 10.1016/j.ijbiomac.2015.04.034. Epub 2015 Apr 28.
7
Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.对用pH依赖性甲基丙烯酸聚合物包衣的吲哚美辛微丸进行统计优化以实现结肠给药的可能性。
Int J Pharm. 2005 Nov 23;305(1-2):22-30. doi: 10.1016/j.ijpharm.2005.08.025. Epub 2005 Oct 19.
8
Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.采用欧巴代S100:L100水分散体包衣的微丸中药物溶出与增塑剂溶出的关系
Int J Pharm. 2006 Oct 12;323(1-2):11-7. doi: 10.1016/j.ijpharm.2006.05.043. Epub 2006 May 27.
9
Interaction and complex formation between catalase and cationic polyelectrolytes: chitosan and Eudragit E100.过氧化氢酶与阳离子聚电解质:壳聚糖和聚丙烯酸树脂E100之间的相互作用及复合物形成
Int J Biol Macromol. 2009 Aug 1;45(2):103-8. doi: 10.1016/j.ijbiomac.2009.04.009. Epub 2009 May 3.
10
Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.制剂和工艺变量对茶碱从直接压片的丙烯酸树脂基质片剂中的体外释放的影响。
Farmaco. 2005 Nov-Dec;60(11-12):913-8. doi: 10.1016/j.farmac.2005.07.002. Epub 2005 Aug 29.

引用本文的文献

1
Biomaterial-Derived Calcium Carbonate Nanoparticles for Enteric Drug Delivery.用于肠溶药物递送的生物材料衍生碳酸钙纳米颗粒
J Nanomater. 2016;2016. doi: 10.1155/2016/3170248.